HomeNDC LookupDrug shortages › Desflurane Liquid For Inhalation

Desflurane Liquid For Inhalation shortage

Desflurane Liquid For Inhalation is currently listed in shortage by the FDA. The FDA lists 1 affected product. This page was last refreshed from FDA data on Sep 22, 2026.

To Be Discontinued ⚠ Supply risk: High Anesthesia 1 product 83 days First posted Jul 2, 2026 Updated Jul 2, 2026
Here’s the bottom line

Jiangsu Hengrui is permanently stopping production of desflurane liquid for inhalation. Suprane (desflurane) 240 mL is still listed as available from Baxter Healthcare Corporation.

Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
1
Affected NDCs
1
Reporting manufacturers
0/1
Reporting mfrs supplying
0/1
Affected sizes supplied
83
Days in shortage
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Sep 22, 2026 · yesterday

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Desflurane Liquid For Inhalation. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
1 NDCs
To be discontinued 1
Affected sizes still supplied
Among manufacturers reporting this shortage
0/1 sizes
No supply 1
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
0/1 makers
No supply 1
✓ Other manufacturers not reporting a shortage
Still-marketed Desflurane Liquid For Inhalation from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Baxter Healthcare Corporation
See all other options & details →
Shortage timeline
  1. Jul 2, 2026
    Currently in shortage
    1 of 1 product affected.
  2. Jul 2, 2026
    First reported to the FDA
    1 product first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) 📞 Sandoz: 800-525-8747 1 NDC click to expand
Status NDC / product Size Availability Related information Reason
To Be Discontinued Desflurane, Liquid for Inhalation, 240 mL/240 mL (NDC 0781-6172-86) NDC 00781-6172-86 Discontinuation of the manufacture of the drug; Distributed by Sandoz, Inc.

These rows are manufacturer reports to the FDA for Desflurane Liquid For Inhalation — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Desflurane Liquid For Inhalation? options further down this page.

Why is Desflurane Liquid For Inhalation in shortage?

Jiangsu Hengrui Pharmaceuticals (whose product is distributed here in the US by Sandoz, Inc.) has reported to the FDA that they are permanently stopping the manufacture of their desflurane liquid for inhalation. The specific product being discontinued is the 240 mL bottle (NDC 0781-6172-86). No specific reason was shared publicly for why they made this decision — just that manufacturing will not be continuing for this product.

It's worth knowing that this report only covers this one manufacturer's version of desflurane. The FDA shortage listing reflects what this particular company filed, so it doesn't mean every version of desflurane from every maker is going away — only this specific 240 mL product from Jiangsu Hengrui/Sandoz is affected by this discontinuation notice.

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Desflurane Liquid For Inhalation, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Desflurane Liquid For Inhalation?

Desflurane Liquid for Inhalation is currently listed on the FDA drug-shortage list. Because this is an inhaled anesthetic used during surgery, this is a product your care team manages rather than something you keep at home — so I want to give you the facts clearly.

The one strength on this record, 240 mL/240 mL, has no available source right now from the manufacturer that filed this report. The reason given is that the maker (distributed by Sandoz) is discontinuing manufacture of the drug. Because the status is listed as "to be discontinued," this particular supply may not return. However, this report reflects only that one manufacturer — the same medicine may still be available from another maker.

Here is what to keep in mind:

  • Do not change any part of your care plan on your own — this medicine is given by your surgical or anesthesia team, who will select what is appropriate.
  • The same medicine, desflurane, is also listed on the market as Suprane (240 mL/240 mL) from Baxter Healthcare Corporation, so your facility may be able to source it, though it may not always be in local stock.
  • Your anesthesia provider can choose a suitable alternative if desflurane cannot be obtained.

Manufacturer contact numbers are listed on this page for reference. This information comes from national, manufacturer-reported FDA data and may not match a specific facility's actual stock.

See “Where else can I get Desflurane Liquid For Inhalation?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Keep reading
Our full Desflurane guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Desflurane guide →

Where else can I get Desflurane Liquid For Inhalation?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Desflurane Liquid For Inhalation is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine, other manufacturers (not reported short)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:

ProductStrengthForm / routeManufacturerNDC
Suprane DESFLURANE 240 mL/240mL Liquid · Respiratory (Inhalation) Baxter Healthcare Corporation 10019-0641-24
Therapeutic equivalents & pricing 6 productsclick to expand

Orange Book–rated equivalents of the affected sizes, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Suprane 240 mL/240mLNDC 00404-9961-25 Henry 1 bottle FDA listed
Desflurane 240 mL/240mLNDC 00781-6172-86 Sandoz 6 bottles FDA listed
Suprane 240 mL/240mLNDC 10019-0641-24 Baxter 6 bottles Discontinued
Suprane 240 mL/240mLNDC 10019-0644-24 Baxter 6 bottles Discontinued
Suprane 240 mL/240mLNDC 10019-0646-24 Baxter 6 bottles Discontinued
Desflurane 250 mL/250mLNDC 66794-0021-25 Piramal 250 ml FDA listed

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of Desflurane Liquid For Inhalation — that fall in the same broad treatment class (general anesthetics,inhalant) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Identity & classification

GCN Seq No 018738
GCN 27120
HICL code 007617
Ingredient (HICL) Desflurane
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H2
Therapeutic class — intermediate (HIC2) Psychoactive Drugs
HIC3 code H2B
Therapeutic class — specific (HIC3) General Anesthetics,Inhalant
AHFS code 28:04.16.00
AHFS class Inhalation Anesthetics
FDB label name DESFLURANE INHALATION LIQUID
FDB brand name Desflurane
Legend status F — Federal legend — prescription drug or device
GPI-1470200007002000
GPI classDesflurane
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other anesthesia shortages

Desflurane Liquid For Inhalation shortage FAQs

Is Desflurane Liquid For Inhalation in shortage?
Yes — the FDA currently lists Desflurane Liquid For Inhalation in shortage (status: “To Be Discontinued”, first reported Jul 2, 2026). 1 of 1 product is affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Which products are affected?
Desflurane, Liquid for Inhalation, 240 mL/240 mL (NDC 0781-6172-86) (NDC 00781-6172-86). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Desflurane Liquid For Inhalation be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Desflurane Liquid For Inhalation somewhere?
Other manufacturers (Baxter Healthcare Corporation) still market it and have not reported a shortage. See “Where else can I get Desflurane Liquid For Inhalation?” above — stock still varies by pharmacy.
What should I do if I take Desflurane Liquid For Inhalation?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out.

Still have a question about the Desflurane Liquid For Inhalation shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages